The global SGLT2 Inhibitors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for SGLT2 Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for SGLT2 Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of SGLT2 Inhibitors include AstraZeneca, Hengrui Medicine, Johnson and Johnson, Kelun Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Hansoh Pharmaceutical Group, Orifarm, Starpharma and Sandoz, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for SGLT2 Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SGLT2 Inhibitors.

Report Scope

The SGLT2 Inhibitors market size, estimations, and forecasts are provided in terms of sales volume (Tablets) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global SGLT2 Inhibitors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the SGLT2 Inhibitors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of SGLT2 Inhibitors Market Report

Report Metric	Details
Report Name	SGLT2 Inhibitors Market
Segment by Type	Canagliflozin Dapagliflozin Other
Segment by Application	Single Drug Combination Medication
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AstraZeneca, Hengrui Medicine, Johnson and Johnson, Kelun Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Hansoh Pharmaceutical Group, Orifarm, Starpharma, Sandoz, Bristol-Myers Squibb, Boehringer Ingelheim, Merck
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of SGLT2 Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of SGLT2 Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the SGLT2 Inhibitors Market report?

Ans: The main players in the SGLT2 Inhibitors Market are AstraZeneca, Hengrui Medicine, Johnson and Johnson, Kelun Pharmaceutical, Chia Tai-Tianqing Pharmaceutical, Hansoh Pharmaceutical Group, Orifarm, Starpharma, Sandoz, Bristol-Myers Squibb, Boehringer Ingelheim, Merck

What are the Application segmentation covered in the SGLT2 Inhibitors Market report?

Ans: The Applications covered in the SGLT2 Inhibitors Market report are Single Drug, Combination Medication

What are the Type segmentation covered in the SGLT2 Inhibitors Market report?

Ans: The Types covered in the SGLT2 Inhibitors Market report are Canagliflozin, Dapagliflozin, Other

1 SGLT2 Inhibitors Market Overview

1.1 Product Overview and Scope of SGLT2 Inhibitors

1.2 SGLT2 Inhibitors Segment by Type

1.2.1 Global SGLT2 Inhibitors Market Value Comparison by Type (2024-2030)

1.2.2 Canagliflozin

1.2.3 Dapagliflozin

1.2.4 Canagliflozin

1.2.5 Other

1.3 SGLT2 Inhibitors Segment by Application

1.3.1 Global SGLT2 Inhibitors Market Value by Application: (2024-2030)

1.3.2 Single Drug

1.3.3 Combination Medication

1.4 Global SGLT2 Inhibitors Market Size Estimates and Forecasts

1.4.1 Global SGLT2 Inhibitors Revenue 2019-2030

1.4.2 Global SGLT2 Inhibitors Sales 2019-2030

1.4.3 Global SGLT2 Inhibitors Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 SGLT2 Inhibitors Market Competition by Manufacturers

2.1 Global SGLT2 Inhibitors Sales Market Share by Manufacturers (2019-2024)

2.2 Global SGLT2 Inhibitors Revenue Market Share by Manufacturers (2019-2024)

2.3 Global SGLT2 Inhibitors Average Price by Manufacturers (2019-2024)

2.4 Global SGLT2 Inhibitors Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of SGLT2 Inhibitors, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of SGLT2 Inhibitors, Product Type & Application

2.7 SGLT2 Inhibitors Market Competitive Situation and Trends

2.7.1 SGLT2 Inhibitors Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest SGLT2 Inhibitors Players Market Share by Revenue

2.7.3 Global SGLT2 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 SGLT2 Inhibitors Retrospective Market Scenario by Region

3.1 Global SGLT2 Inhibitors Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global SGLT2 Inhibitors Global SGLT2 Inhibitors Sales by Region: 2019-2030

3.2.1 Global SGLT2 Inhibitors Sales by Region: 2019-2024

3.2.2 Global SGLT2 Inhibitors Sales by Region: 2025-2030

3.3 Global SGLT2 Inhibitors Global SGLT2 Inhibitors Revenue by Region: 2019-2030

3.3.1 Global SGLT2 Inhibitors Revenue by Region: 2019-2024

3.3.2 Global SGLT2 Inhibitors Revenue by Region: 2025-2030

3.4 North America SGLT2 Inhibitors Market Facts & Figures by Country

3.4.1 North America SGLT2 Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America SGLT2 Inhibitors Sales by Country (2019-2030)

3.4.3 North America SGLT2 Inhibitors Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe SGLT2 Inhibitors Market Facts & Figures by Country

3.5.1 Europe SGLT2 Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe SGLT2 Inhibitors Sales by Country (2019-2030)

3.5.3 Europe SGLT2 Inhibitors Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific SGLT2 Inhibitors Market Facts & Figures by Country

3.6.1 Asia Pacific SGLT2 Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific SGLT2 Inhibitors Sales by Country (2019-2030)

3.6.3 Asia Pacific SGLT2 Inhibitors Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America SGLT2 Inhibitors Market Facts & Figures by Country

3.7.1 Latin America SGLT2 Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America SGLT2 Inhibitors Sales by Country (2019-2030)

3.7.3 Latin America SGLT2 Inhibitors Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa SGLT2 Inhibitors Market Facts & Figures by Country

3.8.1 Middle East and Africa SGLT2 Inhibitors Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa SGLT2 Inhibitors Sales by Country (2019-2030)

3.8.3 Middle East and Africa SGLT2 Inhibitors Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global SGLT2 Inhibitors Sales by Type (2019-2030)

4.1.1 Global SGLT2 Inhibitors Sales by Type (2019-2024)

4.1.2 Global SGLT2 Inhibitors Sales by Type (2025-2030)

4.1.3 Global SGLT2 Inhibitors Sales Market Share by Type (2019-2030)

4.2 Global SGLT2 Inhibitors Revenue by Type (2019-2030)

4.2.1 Global SGLT2 Inhibitors Revenue by Type (2019-2024)

4.2.2 Global SGLT2 Inhibitors Revenue by Type (2025-2030)

4.2.3 Global SGLT2 Inhibitors Revenue Market Share by Type (2019-2030)

4.3 Global SGLT2 Inhibitors Price by Type (2019-2030)

5 Segment by Application

5.1 Global SGLT2 Inhibitors Sales by Application (2019-2030)

5.1.1 Global SGLT2 Inhibitors Sales by Application (2019-2024)

5.1.2 Global SGLT2 Inhibitors Sales by Application (2025-2030)

5.1.3 Global SGLT2 Inhibitors Sales Market Share by Application (2019-2030)

5.2 Global SGLT2 Inhibitors Revenue by Application (2019-2030)

5.2.1 Global SGLT2 Inhibitors Revenue by Application (2019-2024)

5.2.2 Global SGLT2 Inhibitors Revenue by Application (2025-2030)

5.2.3 Global SGLT2 Inhibitors Revenue Market Share by Application (2019-2030)

5.3 Global SGLT2 Inhibitors Price by Application (2019-2030)

6 Key Companies Profiled

6.1 AstraZeneca

6.1.1 AstraZeneca Corporation Information

6.1.2 AstraZeneca Description and Business Overview

6.1.3 AstraZeneca SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.1.4 AstraZeneca SGLT2 Inhibitors Product Portfolio

6.1.5 AstraZeneca Recent Developments/Updates

6.2 Hengrui Medicine

6.2.1 Hengrui Medicine Corporation Information

6.2.2 Hengrui Medicine Description and Business Overview

6.2.3 Hengrui Medicine SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Hengrui Medicine SGLT2 Inhibitors Product Portfolio

6.2.5 Hengrui Medicine Recent Developments/Updates

6.3 Johnson and Johnson

6.3.1 Johnson and Johnson Corporation Information

6.3.2 Johnson and Johnson Description and Business Overview

6.3.3 Johnson and Johnson SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Johnson and Johnson SGLT2 Inhibitors Product Portfolio

6.3.5 Johnson and Johnson Recent Developments/Updates

6.4 Kelun Pharmaceutical

6.4.1 Kelun Pharmaceutical Corporation Information

6.4.2 Kelun Pharmaceutical Description and Business Overview

6.4.3 Kelun Pharmaceutical SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Kelun Pharmaceutical SGLT2 Inhibitors Product Portfolio

6.4.5 Kelun Pharmaceutical Recent Developments/Updates

6.5 Chia Tai-Tianqing Pharmaceutical

6.5.1 Chia Tai-Tianqing Pharmaceutical Corporation Information

6.5.2 Chia Tai-Tianqing Pharmaceutical Description and Business Overview

6.5.3 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product Portfolio

6.5.5 Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates

6.6 Hansoh Pharmaceutical Group

6.6.1 Hansoh Pharmaceutical Group Corporation Information

6.6.2 Hansoh Pharmaceutical Group Description and Business Overview

6.6.3 Hansoh Pharmaceutical Group SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Hansoh Pharmaceutical Group SGLT2 Inhibitors Product Portfolio

6.6.5 Hansoh Pharmaceutical Group Recent Developments/Updates

6.7 Orifarm

6.6.1 Orifarm Corporation Information

6.6.2 Orifarm Description and Business Overview

6.6.3 Orifarm SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Orifarm SGLT2 Inhibitors Product Portfolio

6.7.5 Orifarm Recent Developments/Updates

6.8 Starpharma

6.8.1 Starpharma Corporation Information

6.8.2 Starpharma Description and Business Overview

6.8.3 Starpharma SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Starpharma SGLT2 Inhibitors Product Portfolio

6.8.5 Starpharma Recent Developments/Updates

6.9 Sandoz

6.9.1 Sandoz Corporation Information

6.9.2 Sandoz Description and Business Overview

6.9.3 Sandoz SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Sandoz SGLT2 Inhibitors Product Portfolio

6.9.5 Sandoz Recent Developments/Updates

6.10 Bristol-Myers Squibb

6.10.1 Bristol-Myers Squibb Corporation Information

6.10.2 Bristol-Myers Squibb Description and Business Overview

6.10.3 Bristol-Myers Squibb SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Bristol-Myers Squibb SGLT2 Inhibitors Product Portfolio

6.10.5 Bristol-Myers Squibb Recent Developments/Updates

6.11 Boehringer Ingelheim

6.11.1 Boehringer Ingelheim Corporation Information

6.11.2 Boehringer Ingelheim SGLT2 Inhibitors Description and Business Overview

6.11.3 Boehringer Ingelheim SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Boehringer Ingelheim SGLT2 Inhibitors Product Portfolio

6.11.5 Boehringer Ingelheim Recent Developments/Updates

6.12 Merck

6.12.1 Merck Corporation Information

6.12.2 Merck SGLT2 Inhibitors Description and Business Overview

6.12.3 Merck SGLT2 Inhibitors Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Merck SGLT2 Inhibitors Product Portfolio

6.12.5 Merck Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 SGLT2 Inhibitors Industry Chain Analysis

7.2 SGLT2 Inhibitors Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 SGLT2 Inhibitors Production Mode & Process

7.4 SGLT2 Inhibitors Sales and Marketing

7.4.1 SGLT2 Inhibitors Sales Channels

7.4.2 SGLT2 Inhibitors Distributors

7.5 SGLT2 Inhibitors Customers

8 SGLT2 Inhibitors Market Dynamics

8.1 SGLT2 Inhibitors Industry Trends

8.2 SGLT2 Inhibitors Market Drivers

8.3 SGLT2 Inhibitors Market Challenges

8.4 SGLT2 Inhibitors Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Chia Tai-Tianqing Pharmaceutical

Hansoh Pharmaceutical Group

List of Tables

Table 1. Global SGLT2 Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global SGLT2 Inhibitors Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global SGLT2 Inhibitors Market Competitive Situation by Manufacturers in 2023

Table 4. Global SGLT2 Inhibitors Sales (Tablets) of Key Manufacturers (2019-2024)

Table 5. Global SGLT2 Inhibitors Sales Market Share by Manufacturers (2019-2024)

Table 6. Global SGLT2 Inhibitors Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global SGLT2 Inhibitors Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market SGLT2 Inhibitors Average Price (US$/Tablets) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of SGLT2 Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of SGLT2 Inhibitors, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of SGLT2 Inhibitors, Product Type & Application

Table 12. Global Key Manufacturers of SGLT2 Inhibitors, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global SGLT2 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SGLT2 Inhibitors as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global SGLT2 Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global SGLT2 Inhibitors Sales by Region (2019-2024) & (Tablets)

Table 18. Global SGLT2 Inhibitors Sales Market Share by Region (2019-2024)

Table 19. Global SGLT2 Inhibitors Sales by Region (2025-2030) & (Tablets)

Table 20. Global SGLT2 Inhibitors Sales Market Share by Region (2025-2030)

Table 21. Global SGLT2 Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global SGLT2 Inhibitors Revenue Market Share by Region (2019-2024)

Table 23. Global SGLT2 Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global SGLT2 Inhibitors Revenue Market Share by Region (2025-2030)

Table 25. North America SGLT2 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America SGLT2 Inhibitors Sales by Country (2019-2024) & (Tablets)

Table 27. North America SGLT2 Inhibitors Sales by Country (2025-2030) & (Tablets)

Table 28. North America SGLT2 Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America SGLT2 Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe SGLT2 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe SGLT2 Inhibitors Sales by Country (2019-2024) & (Tablets)

Table 32. Europe SGLT2 Inhibitors Sales by Country (2025-2030) & (Tablets)

Table 33. Europe SGLT2 Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe SGLT2 Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific SGLT2 Inhibitors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific SGLT2 Inhibitors Sales by Region (2019-2024) & (Tablets)

Table 37. Asia Pacific SGLT2 Inhibitors Sales by Region (2025-2030) & (Tablets)

Table 38. Asia Pacific SGLT2 Inhibitors Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific SGLT2 Inhibitors Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America SGLT2 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America SGLT2 Inhibitors Sales by Country (2019-2024) & (Tablets)

Table 42. Latin America SGLT2 Inhibitors Sales by Country (2025-2030) & (Tablets)

Table 43. Latin America SGLT2 Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America SGLT2 Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa SGLT2 Inhibitors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa SGLT2 Inhibitors Sales by Country (2019-2024) & (Tablets)

Table 47. Middle East & Africa SGLT2 Inhibitors Sales by Country (2025-2030) & (Tablets)

Table 48. Middle East & Africa SGLT2 Inhibitors Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa SGLT2 Inhibitors Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global SGLT2 Inhibitors Sales (Tablets) by Type (2019-2024)

Table 51. Global SGLT2 Inhibitors Sales (Tablets) by Type (2025-2030)

Table 52. Global SGLT2 Inhibitors Sales Market Share by Type (2019-2024)

Table 53. Global SGLT2 Inhibitors Sales Market Share by Type (2025-2030)

Table 54. Global SGLT2 Inhibitors Revenue (US$ Million) by Type (2019-2024)

Table 55. Global SGLT2 Inhibitors Revenue (US$ Million) by Type (2025-2030)

Table 56. Global SGLT2 Inhibitors Revenue Market Share by Type (2019-2024)

Table 57. Global SGLT2 Inhibitors Revenue Market Share by Type (2025-2030)

Table 58. Global SGLT2 Inhibitors Price (US$/Tablets) by Type (2019-2024)

Table 59. Global SGLT2 Inhibitors Price (US$/Tablets) by Type (2025-2030)

Table 60. Global SGLT2 Inhibitors Sales (Tablets) by Application (2019-2024)

Table 61. Global SGLT2 Inhibitors Sales (Tablets) by Application (2025-2030)

Table 62. Global SGLT2 Inhibitors Sales Market Share by Application (2019-2024)

Table 63. Global SGLT2 Inhibitors Sales Market Share by Application (2025-2030)

Table 64. Global SGLT2 Inhibitors Revenue (US$ Million) by Application (2019-2024)

Table 65. Global SGLT2 Inhibitors Revenue (US$ Million) by Application (2025-2030)

Table 66. Global SGLT2 Inhibitors Revenue Market Share by Application (2019-2024)

Table 67. Global SGLT2 Inhibitors Revenue Market Share by Application (2025-2030)

Table 68. Global SGLT2 Inhibitors Price (US$/Tablets) by Application (2019-2024)

Table 69. Global SGLT2 Inhibitors Price (US$/Tablets) by Application (2025-2030)

Table 70. AstraZeneca Corporation Information

Table 71. AstraZeneca Description and Business Overview

Table 72. AstraZeneca SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 73. AstraZeneca SGLT2 Inhibitors Product

Table 74. AstraZeneca Recent Developments/Updates

Table 75. Hengrui Medicine Corporation Information

Table 76. Hengrui Medicine Description and Business Overview

Table 77. Hengrui Medicine SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 78. Hengrui Medicine SGLT2 Inhibitors Product

Table 79. Hengrui Medicine Recent Developments/Updates

Table 80. Johnson and Johnson Corporation Information

Table 81. Johnson and Johnson Description and Business Overview

Table 82. Johnson and Johnson SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 83. Johnson and Johnson SGLT2 Inhibitors Product

Table 84. Johnson and Johnson Recent Developments/Updates

Table 85. Kelun Pharmaceutical Corporation Information

Table 86. Kelun Pharmaceutical Description and Business Overview

Table 87. Kelun Pharmaceutical SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 88. Kelun Pharmaceutical SGLT2 Inhibitors Product

Table 89. Kelun Pharmaceutical Recent Developments/Updates

Table 90. Chia Tai-Tianqing Pharmaceutical Corporation Information

Table 91. Chia Tai-Tianqing Pharmaceutical Description and Business Overview

Table 92. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 93. Chia Tai-Tianqing Pharmaceutical SGLT2 Inhibitors Product

Table 94. Chia Tai-Tianqing Pharmaceutical Recent Developments/Updates

Table 95. Hansoh Pharmaceutical Group Corporation Information

Table 96. Hansoh Pharmaceutical Group Description and Business Overview

Table 97. Hansoh Pharmaceutical Group SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 98. Hansoh Pharmaceutical Group SGLT2 Inhibitors Product

Table 99. Hansoh Pharmaceutical Group Recent Developments/Updates

Table 100. Orifarm Corporation Information

Table 101. Orifarm Description and Business Overview

Table 102. Orifarm SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 103. Orifarm SGLT2 Inhibitors Product

Table 104. Orifarm Recent Developments/Updates

Table 105. Starpharma Corporation Information

Table 106. Starpharma Description and Business Overview

Table 107. Starpharma SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 108. Starpharma SGLT2 Inhibitors Product

Table 109. Starpharma Recent Developments/Updates

Table 110. Sandoz Corporation Information

Table 111. Sandoz Description and Business Overview

Table 112. Sandoz SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 113. Sandoz SGLT2 Inhibitors Product

Table 114. Sandoz Recent Developments/Updates

Table 115. Bristol-Myers Squibb Corporation Information

Table 116. Bristol-Myers Squibb Description and Business Overview

Table 117. Bristol-Myers Squibb SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 118. Bristol-Myers Squibb SGLT2 Inhibitors Product

Table 119. Bristol-Myers Squibb Recent Developments/Updates

Table 120. Boehringer Ingelheim Corporation Information

Table 121. Boehringer Ingelheim Description and Business Overview

Table 122. Boehringer Ingelheim SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 123. Boehringer Ingelheim SGLT2 Inhibitors Product

Table 124. Boehringer Ingelheim Recent Developments/Updates

Table 125. Merck Corporation Information

Table 126. Merck Description and Business Overview

Table 127. Merck SGLT2 Inhibitors Sales (Tablets), Revenue (US$ Million), Price (US$/Tablets) and Gross Margin (2019-2024)

Table 128. Merck SGLT2 Inhibitors Product

Table 129. Merck Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. SGLT2 Inhibitors Distributors List

Table 133. SGLT2 Inhibitors Customers List

Table 134. SGLT2 Inhibitors Market Trends

Table 135. SGLT2 Inhibitors Market Drivers

Table 136. SGLT2 Inhibitors Market Challenges

Table 137. SGLT2 Inhibitors Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of SGLT2 Inhibitors

Figure 2. Global SGLT2 Inhibitors Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global SGLT2 Inhibitors Market Share by Type in 2023 & 2030

Figure 4. Canagliflozin Product Picture

Figure 5. Dapagliflozin Product Picture

Figure 6. Canagliflozin Product Picture

Figure 7. Other Product Picture

Figure 8. Global SGLT2 Inhibitors Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global SGLT2 Inhibitors Market Share by Application in 2023 & 2030

Figure 10. Single Drug

Figure 11. Combination Medication

Figure 12. Global SGLT2 Inhibitors Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global SGLT2 Inhibitors Market Size (2019-2030) & (US$ Million)

Figure 14. Global SGLT2 Inhibitors Sales (2019-2030) & (Tablets)

Figure 15. Global SGLT2 Inhibitors Average Price (US$/Tablets) & (2019-2030)

Figure 16. SGLT2 Inhibitors Report Years Considered

Figure 17. SGLT2 Inhibitors Sales Share by Manufacturers in 2023

Figure 18. Global SGLT2 Inhibitors Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest SGLT2 Inhibitors Players: Market Share by Revenue in 2023

Figure 20. SGLT2 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global SGLT2 Inhibitors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America SGLT2 Inhibitors Sales Market Share by Country (2019-2030)

Figure 23. North America SGLT2 Inhibitors Revenue Market Share by Country (2019-2030)

Figure 24. United States SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe SGLT2 Inhibitors Sales Market Share by Country (2019-2030)

Figure 27. Europe SGLT2 Inhibitors Revenue Market Share by Country (2019-2030)

Figure 28. Germany SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific SGLT2 Inhibitors Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific SGLT2 Inhibitors Revenue Market Share by Region (2019-2030)

Figure 35. China SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America SGLT2 Inhibitors Sales Market Share by Country (2019-2030)

Figure 43. Latin America SGLT2 Inhibitors Revenue Market Share by Country (2019-2030)

Figure 44. Mexico SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Brazil SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Argentina SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa SGLT2 Inhibitors Sales Market Share by Country (2019-2030)

Figure 48. Middle East & Africa SGLT2 Inhibitors Revenue Market Share by Country (2019-2030)

Figure 49. Turkey SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE SGLT2 Inhibitors Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of SGLT2 Inhibitors by Type (2019-2030)

Figure 53. Global Revenue Market Share of SGLT2 Inhibitors by Type (2019-2030)

Figure 54. Global SGLT2 Inhibitors Price (US$/Tablets) by Type (2019-2030)

Figure 55. Global Sales Market Share of SGLT2 Inhibitors by Application (2019-2030)

Figure 56. Global Revenue Market Share of SGLT2 Inhibitors by Application (2019-2030)

Figure 57. Global SGLT2 Inhibitors Price (US$/Tablets) by Application (2019-2030)

Figure 58. SGLT2 Inhibitors Value Chain

Figure 59. SGLT2 Inhibitors Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Distributors Profiles

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions